该词条未找到_海词词典

您要查找的是不是：

The LST cell strain derived from villous adenoma displayed various atypical hyperplasia. LST细胞株的组织来源为轻度不典型增生绒毛状腺瘤。
Objective To investigate the changes of laminin(LN) and fibronectin(FN) expressions in atypical hyperplasia and breast cancer. 目的观察层粘连蛋白 (Laminin ,LN)和纤维连接蛋白 (Fibronectin ,FN)在乳腺不典型增生及乳腺癌中表达的变化。
The expression level of PTEN decreased progressively, and was 95.0%, 40.0%, 31.1% respectively in normal, atypical hyperplasia endometrium and EEC. PTEN在正常子宫内膜、不典型增生和内膜腺癌中的阳性表达率逐渐降低;分别为95.;0%25、40
The results showed an efficacy of Sanqi on the chronic atrophic gastritis, which could also reverse the intestinal metaplasia and atypical hyperplasia. 结果表明三七对慢性萎缩性胃炎有较好的治疗作用，并能逆转肠上皮化生及不典型增生；
Having certain types of abnormal cells (atypical hyperplasia and lobular carcinoma in situ [LCIS]) increases the risk of breast cancer. 有不同类型的异常细胞（如不典型增生和原处小叶癌）也增加了患乳腺癌的风险。
Objective To investigate the role of mutations of P53 gene in the atypical hyperplasia of bronchus epithelia and carcinogenesis of lung. 摘要目的探讨P53基因突变在肺癌癌前病变（支气管黏膜上皮不典型增生）和肺癌中的作用。
The abnormalities of superficial cells included squamous epithelium metaplasia, atypical hyperplasia and squamous carcinoma. 表层细胞的主要病理改变包括鳞状上皮化生、非典型增生和鳞状细胞癌。
Those patients whose postoperative pathology is leukoplakia with moderate or severe atypical hyperplasia should be followed up closely. 对手术后病理为喉白斑病伴中或重度不典型增生者应严密随访。
We report the histopathologic distinctions among BCH,atypical hyperplasia,basaloid carcinoma,prostatic intraepithelial neoplasia,adenocarcinoma,adenosis,and atrophy. 此病变需与不典型增生、上皮内瘤、腺癌、腺病和腺体萎缩鉴别
The histologic study proved 61 prostate cancer(PCA),182 benign prostate hyperplasia(BPH), 12 atypical hyperplasia,6 prostatic intraepithelial neoplasia(PIN), 2 tuberculosis (TB). 263例前列腺穿刺活检中组织学证实前列腺癌(PCA)61例、良性前列腺增生(BPH)182例、前列腺不典型增生12例、前列腺上皮内肿瘤6例和前列腺结核2例。
Results Among 76 cases there were 8 cases of severe atypical hyperplasia,6 cases of papillary hyperplasia,4 cases of tubular adenosis and others were simple hyperplasia. 结果76例中，有8例重度不典型增生，6例乳头状瘤样增生，4例腺管型腺病，其它仅上皮增生。
Inflammations on different degrees were found in all patients with pathological examination, intestinal metaplasia (IM) and atypical hyperplasia were also found in some cases. 病理检查都有不同程度的炎症，有的伴有肠上皮化生及不典型增生。
Objective To design a new operation for bilateral mammary atypical hyperplasia, which can not only prevent breast cancer by mammary gland ectomy, but also keep the breast contour. 目的探讨双侧乳腺重度增生时,既能彻底切除,防止癌变,又能保持乳房外形的术式。
Objective To study the relationship between gastric cancer and the atypical hyperplasia,intestinal metaplasia and atypical cystic dilatation of gastric mucous membranes. 目的研究胃黏膜(中、重度)异型增生、肠上皮化生及异型性囊性扩张三种癌前病变与胃癌发生的关系。
Dupont WD,Parl FF,Hart mann WH,et al.Breast cancer risk associated with proliferative breast disease and atypical hyperplasia[J].Cancer,2003;71(4):1258. 江泽飞;徐兵河;宋三泰;等.;乳腺癌内分泌治疗的基本共识[J]
Conclusion Cyctomastopathy atypical hyperplasia was regarded as an important pathologic change was breast cancer, and it can develop carcinoma in situ under given conditions. 结论乳腺增生症中不典型增生为重要癌旁病变，在一定条件下可发展成原位癌。
The positive immunnostaining rates of p21ras in normal, atypical hyperplasia endometrium and EEC were 0, 50.0%, 64.4%, respectively. The expression level of p21ras increased progressively from normal to EEC, with significant difference(P <0.01). p21ras蛋白在正常子宫内膜、不典型增生和子宫内膜腺癌中的阳性表达率分别为0、50.;0%25、64
The positive rates of IGF-1R and VEGF in gastric adenocarcinoma tissue and in atypical hyperplasia tissue adjacent to the cancer were significantly higher than those in the normal gastric tissue(P<0.05). 胃腺癌组织、癌旁不典型增生组织中IGF-1R和VEGF的阳性表达率显著高于正常胃组织(P<0.;05);
Objective To analyze the expression of CD44_(V6), MMP-2,MMP-9 and their inhibitor TIMP-1,TIMP-2 in tissue of endometrial hyperplasia, then to investigate their clinical value in diagnose and treatment in atypical hyperplasia of endometrium (AH). 目的研究子宫内膜增殖症组织中CD44V6、基质金属蛋白酶MMP-2、MMP-9及其抑制物:组织金属蛋白酶抑制剂TIMP-1、TIMP-2的表达,探讨它们在子宫内膜不典型增生诊断、治疗中的价值。
The result showed that within 40 weeks, there were atypical hyperplasia (5, 6, 5, 4 cases separately); carcinoma in situ (3, 1, 1, 1 cases separately); infiltrating carcinoma (1 case in large dose serial DNP and PMA administered group). 在40周内，分别见不典型性增生及异型鳞状化生5、6、6及7例次，原位癌依次为3、1、1及1例，而大剂量DNP＋PMA组及低剂量多次给药组各诱发浸润癌一例。